BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 11464425)

  • 1. Decomposing pharmaceutical cost growth in different types of health plans.
    Chernew ME; Smith DG; Kirking DM; Fendrick AM
    Am J Manag Care; 2001 Jul; 7(7):667-73. PubMed ID: 11464425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Managing drug costs: the perception of managed care pharmacy directors.
    Litton LM; Sisk FA; Akins ME
    Am J Manag Care; 2000 Jul; 6(7):805-14. PubMed ID: 11067377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in prescription drug use in HMO and self-insured health plans.
    Wallack SS; Thomas CP; Martin TC; Ryan A
    Med Care Res Rev; 2007 Feb; 64(1):98-116. PubMed ID: 17213460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does competition by health maintenance organizations affect the adoption of cost-containment measures by fee-for-service plans?
    Joesch JM; Wickizer TM; Feldstein PJ
    Am J Manag Care; 1998 Jun; 4(6):832-8. PubMed ID: 10181069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the effect of a consumer-driven health plan on medical care expenditures and utilization.
    Parente ST; Feldman R; Christianson JB
    Health Serv Res; 2004 Aug; 39(4 Pt 2):1189-210. PubMed ID: 15230920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Healthcare utilization in community-acquired pneumonia episodes of care: a comparison across the continuum of managed care.
    Landsman PB; Smith DG; Fendrick AM
    Med Care; 2009 Oct; 47(10):1084-90. PubMed ID: 19648830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The direct and indirect effects of cost-sharing on the use of preventive services.
    Solanki G; Schauffler HH; Miller LS
    Health Serv Res; 2000 Feb; 34(6):1331-50. PubMed ID: 10654834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Features of employment-based health plans.
    Fronstin P
    EBRI Issue Brief; 1998 Sep; (201):1-21. PubMed ID: 10345788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How effectively do managed care organizations influence prescribing and dispensing decisions?
    Carroll NV
    Am J Manag Care; 2002 Dec; 8(12):1041-54. PubMed ID: 12500881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in drug economy in Israel's health maintenance organizations in the wake of the National Health Insurance Law.
    Sax P
    Isr Med Assoc J; 2001 Aug; 3(8):605-9. PubMed ID: 11519388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spending on medicines in Israel in an international context.
    Sax P
    Isr Med Assoc J; 2005 May; 7(5):286-91. PubMed ID: 15909459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in prescription drug expenditures by Medicaid enrollees.
    Banthin JS; Miller GE
    Med Care; 2006 May; 44(5 Suppl):I27-35. PubMed ID: 16625061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seniors' prescription drug cost inflation and cost containment: evidence from British Columbia.
    Morgan SG; Agnew JD; Barer ML
    Health Policy; 2004 Jun; 68(3):299-307. PubMed ID: 15113641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of insurance type on prescription drug use and expenditures among elderly Medicare beneficiaries.
    Saleh SS; Weller W; Hannan E
    J Health Hum Serv Adm; 2007; 30(1):50-74. PubMed ID: 17557696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of HMO competition on private health insurance premiums, 1985-1992.
    Wickizer TM; Feldstein PJ
    Inquiry; 1995; 32(3):241-51. PubMed ID: 7591039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. As drug costs rise, health plans shift the burden.
    Capitation Manag Rep; 1997 Oct; 4(10):153-8. PubMed ID: 10175783
    [No Abstract]   [Full Text] [Related]  

  • 17. Employee responses to health insurance premium increases.
    Goldman DP; Leibowitz AA; Robalino DA
    Am J Manag Care; 2004 Jan; 10(1):41-7. PubMed ID: 14738186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weaker HMOs will seek concessions from hospitals for 2002 as medical cost rise.
    Health Care Strateg Manage; 2001 Jun; 19(6):16-7, 1. PubMed ID: 11409092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of HMOs on fee-for-service health care expenditures: evidence from Medicare revisited.
    Batata A
    J Health Econ; 2004 Sep; 23(5):951-63. PubMed ID: 15353188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The price of pharmaceuticals given managed care health insurance membership.
    Brotman BA
    Pharm Pract Manag Q; 2000 Jul; 20(2):16-9. PubMed ID: 11184047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.